Personnel Training Under GMP: What FDA Expects Now

Personnel training is having a moment it probably shouldn't be having. It is the oldest requirement in the GMP book, written into 21 CFR 211.25 since the modern drug CGMPs were finalized, yet it keeps resurfacing as a live compliance risk. Part of that is a pattern I keep seeing in the facilities I work with: a plant can pass every analytical test and still draw a Form 483 observation — FDA's formal notice of an inspection finding — because an operator couldn't explain why a deviation procedure existed. Part of it is a genuinely new wrinkle. In the client engagements I've supported, quality organizations are starting to move training records into AI-assisted learning management systems, and nobody has fully worked out what "qualified individual" means when an algorithm is doing the assigning and tracking.

I want to walk through what the regulations actually say, where firms in drugs, dietary supplements, food, and cosmetics diverge, and what a defensible training program looks like when an investigator asks to see it.

Why Personnel Training Is Back Under the Microscope

Training sits at an odd intersection in a quality system. It's not a test result, not a batch record, not a specification, so it's easy to treat as administrative overhead rather than a control. But every other control in a facility, from environmental monitoring to change control to data integrity, depends on someone who was trained to execute it correctly and trained to recognize when something has gone wrong. When an investigator can't get a straight answer from line staff about a basic procedure, the finding rarely lands on the operator. It lands on the training program that was supposed to prepare them.

The current attention also traces to two converging trends. First, in the inspections I've supported, investigators lean harder on direct staff interviews than on paper review alone, which surfaces training gaps that a well-organized binder can hide. Second, the rise of digital and AI-assisted learning platforms means training completion is increasingly generated by a system rather than signed by a supervisor, and quality units are still figuring out what evidence of competence needs to look like when that's true. I've written separately about the validation questions AI systems raise more broadly in GMP environments, and training records are one of the first places that tension shows up in practice.

None of this changes the underlying rule. It just raises the odds that someone checks whether you're actually following it.

What the Regulations Require, Industry by Industry

The specific citation changes depending on what you manufacture, but the underlying logic is consistent: a written basis for qualification, training tied to the job actually performed, and a way to prove both happened.

The rule that trips up the most facilities I work with is 21 CFR 211.25(a). It requires that CGMP training be "conducted by qualified individuals on a continuing basis and with sufficient frequency to assure that employees remain familiar with CGMP requirements applicable to them." FDA deliberately did not specify an interval. That's not an oversight, it's a design choice that puts the burden on the firm to define and defend its own frequency, which means "we do it annually" is only a defensible answer if you can show why annual is sufficient for the risk profile of the role in question.

Education, Training, and Experience Are Three Separate Doors

Under 21 CFR 211.25(a), education, training, and experience are three distinct, independently sufficient pathways to competence. That distinction matters more than it sounds. A microbiologist with a master's degree still needs facility-specific, procedure-specific training before running an environmental monitoring program in your cleanroom. A twenty-year production veteran hired from a competitor still needs CGMP orientation and site-specific qualification before touching your equipment. A degree does not substitute for hands-on qualification, and tenure does not substitute for site-specific onboarding. Investigators ask about this distinction directly, usually by asking a new employee what training they received before they were allowed to work independently, and a vague answer is itself the finding.

The same logic runs through 21 CFR 111.12 for dietary supplement manufacturers and 21 CFR 117.4 for food facilities. Neither regulation cares whether your operator has a diploma if that operator can't demonstrate they know how to execute the specific unit operation they're assigned to, following the specific written procedure that governs it.

Documentation: The Training That Isn't Written Down Didn't Happen

Every one of these regulations shares an unstated corollary: training that can't be reconstructed on paper is functionally equivalent to training that never occurred, at least from an inspection standpoint. That means a training record needs to identify who was trained, on what document or procedure, by whom, on what date, and how competence was verified, whether that's a signed acknowledgment, a written test, a supervised run-through, or a combination.

The verification step is where I see the most gaps. A lot of programs stop at "employee read and acknowledged the SOP," which satisfies the letter of documentation but not the intent of the regulation. Reading a procedure is not the same as demonstrating you can perform it, and if your training program can't distinguish between the two, neither can an investigator reviewing it. A stronger program builds in a competency check appropriate to the risk of the task: a quiz for a low-risk administrative procedure, a supervised observation for an aseptic technique, a practical demonstration for equipment operation.

How Often Is "Continuing Basis"?

Because none of the core regulations specify a fixed interval, most mature quality systems build a tiered frequency schedule based on role risk rather than a blanket calendar date. A typical structure looks like this:

• Initial qualification before independent performance of any GMP-impacting task, regardless of prior experience elsewhere.
• Periodic refresher training, commonly annual for general CGMP awareness, but shorter cycles for high-risk operations like aseptic processing or potent compound handling.
• Event-triggered retraining following a deviation, CAPA (Corrective and Preventive Action), procedure revision, or repeat human-error trend, which is where a lot of programs quietly fall short because retraining gets treated as a checkbox closure action rather than a genuine competency rebuild.
• Retraining on procedure revision, since a signature on the original SOP doesn't cover a materially changed version.

ICH Q10 frames training as an enabler of the pharmaceutical quality system rather than a standalone requirement, which is the right way to think about frequency: the schedule should track the actual risk the task carries, not an arbitrary calendar convenience.

The AI and Digital LMS Question

Digital learning management systems have been standard in regulated manufacturing for years, but the shift toward AI-assisted assignment, content generation, and completion tracking is newer. It raises a question quality units haven't fully resolved: if a system decides what training an employee needs and confirms they've completed it, who is the "qualified individual" conducting that training under 21 CFR 211.25(a)?

The honest answer is that the regulation doesn't change because the tooling did. A learning platform can automate scheduling, track completion, and flag overdue assignments, all of which are genuine improvements over spreadsheet-based tracking. What it cannot do on its own is satisfy the competency-verification intent of the rule, unless the system's outputs are themselves validated and a qualified human remains accountable for confirming the employee can actually perform the task. If you're introducing AI-driven training tools into a regulated environment, the validation questions are the same ones that apply to any GMP-adjacent AI system. What does the tool actually decide, what's the human check on that decision, and can you reconstruct its logic during an inspection?

Common Gaps I See in Practice

A few patterns show up across drug, supplement, food, and cosmetic manufacturers alike, regardless of size:

1. Generic onboarding, no role-specific qualification. New hires get a CGMP overview video and a stack of SOPs to sign, but never a documented, task-specific qualification before working independently.
2. Training records that don't match the current SOP revision. An employee's file shows they were trained on Rev. 3 of a procedure that's now on Rev. 6, with no evidence of retraining in between.
3. No effectiveness check. Attendance is documented; comprehension is not.
4. Trainers who were never qualified to train. 211.25(a) requires training be conducted by "qualified individuals," which means the trainer's own qualification needs to be documented, not assumed because they've been on staff a long time.
5. Retraining treated as a CAPA closure formality. A deviation investigation identifies human error, retraining is assigned, and the retraining consists of re-reading the same SOP that didn't work the first time, with no root-cause-informed change to how the material is delivered.

Building a Program That Holds Up

A defensible personnel training program does a few things consistently well. It ties every training assignment to a specific job function rather than a generic department. It documents a competency verification method appropriate to the risk of the task, not just an acknowledgment signature. It maintains a clear, auditable link between SOP revisions and retraining records, so a revision history and a training history tell the same story. And it treats the trainer's own qualification as a documented fact, not an assumption.

None of that requires exotic tooling. It requires discipline about what "trained" means before you write it down as complete. If your quality system already has strong document control and CAPA processes, extending that same rigor to training is usually a matter of tightening existing procedures rather than building something new. For teams standing up a training function for the first time, or rebuilding one after an inspection finding, working through the first 90 days of a GMP program in a structured order matters more than trying to fix everything at once.

FAQ

How often does GMP personnel training have to be repeated? The core regulations, including 21 CFR 211.25(a) for drugs, don't set a fixed interval. They require training "on a continuing basis and with sufficient frequency" to keep employees current. Most mature programs default to annual CGMP refreshers plus event-triggered retraining after deviations, CAPAs, or SOP revisions.

What's the difference between training and qualification? Training is the instruction itself, whether that's reading an SOP, attending a session, or completing an e-learning module. Qualification is the documented confirmation that the person can actually perform the task correctly, through a test, supervised observation, or practical demonstration. A program that only documents training without qualification hasn't fully met the intent of 21 CFR 211.25 or 21 CFR 111.12.

Can e-learning or AI-driven platforms satisfy GMP training requirements? They can handle scheduling, content delivery, and completion tracking, but the underlying regulations still require a qualified individual to stand behind the training's adequacy and a documented method of verifying competence. An automated completion record without a competency check doesn't fully satisfy 21 CFR 211.25(a).

Does 21 CFR 117.4 for food facilities require the same level of documentation as drug CGMPs? It requires training commensurate with the employee's duties, including food safety and hygiene, and while it's less prescriptive than 21 CFR 211.25, FDA investigators under FSMA's Preventive Controls rule still expect documented evidence that training occurred and was appropriate to the role.

What should a training record include at minimum? The employee's name, the specific procedure or topic covered, the date, the trainer's name and qualification, and the method used to verify competence, whether that's a signed acknowledgment, a written assessment, or a supervised demonstration.

If your training program hasn't been stress-tested against how an investigator will actually probe it, that's a gap worth closing before someone else finds it for you. Reach out through Certify Consulting to talk through where your program stands, including how a first-90-days GMP engagement is structured.

Related reading: GMP Training Requirements for Manufacturing Staff and Validating AI Systems in FDA-Regulated GMP Environments.

Last updated: 2026-08-21